Medical Communications

Showing 15 posts of 6402 posts found.

nasal_spray

Ena Respiratory’s nasal spray reduces COVID-19 replication by 96%

December 18, 2020 Medical Communications COVID-19, Nasal Spray

Australian biotech Ena Respiratory has revealed that its self-administered nasal spray INNA-051, when taken once or twice weekly, reduced viral …
biogen

Biogen agrees to pay $22m to settle kickback allegations

December 18, 2020 Medical Communications Biogen, multiple sclerosis

Biogen has agreed to pay $22 million to put an end to an investigation into claims that it illegally used …
1_1

Samsung Biologics names John Rim as CEO and President

December 17, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Samsung BioLogics

Samsung Biologics has appointed John Rim as the company’s President and CEO. The appointment was made effective immediately and formalised via the …

How COVID-19 is affecting diabetics and their access to insulin in America

December 15, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Diabetic patients face daily challenges of treatment access and treatment management, so 2020 has been a particularly challenging year. Conor …
image_3

PPAs – Ready to make a long-term commitment to zero carbon?

December 14, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Energy, sustainability

As an industry that consumes a large amount of energy, the pressure is on for the pharmaceutical sector to achieve …

PPAs – Ready to make a long-term commitment to zero carbon?

December 14, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Energy, sustainability

As an industry that consumes a large amount of energy, the pressure is on for the pharmaceutical sector to achieve …
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

December 11, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, COVID-19, Pfizer, Vaccine, pharma, top 10

With just around three weeks until the end of a long year, rapidly emerging news around the leading COVID-19 vaccine …
spravato

Janssen’s esketamine nasal spray secures CHMP recommendation in Europe for the rapid reduction of depressive symptoms in a psychiatric emergency for patients with major depressive disorder

December 11, 2020 Medical Communications EMA, Europe, Spravato, depression

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has moved to recommend Janssen’s …
vaccination-1215279_960_720

Sanofi/GSK COVID-19 vaccine development delayed after failing to induce strong response in over-50s

December 11, 2020 Medical Communications, Research and Development COVID-19, GSK, Sanofi, Vaccine

Sanofi and GlaxoSmithKline have taken the decision to delay the development programme for their adjuvanted recombinant protein-based COVID-19 vaccine after …

FDA advisory panel recommends US approval of Pfizer/BioNTech’s COVID-19 vaccine

December 11, 2020 Medical Communications, Sales and Marketing COVID-19, FDA, Vaccine

An advisory panel on behalf of the FDA has strongly recommended that Pfizer and BioNTech’s COVID-19 vaccine BNT162b2 be approved …

NICE backs Novartis’ Aimovig for prevention of episodic and chronic migraine

December 11, 2020 Medical Communications, Sales and Marketing Aimovig, NICE, Novartis, migraine

NICE has announced its decision to recommended Novartis’ Aimovig (erenumab) for the prevention of migraine, including both episodic and chronic …
covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

December 9, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Top 5, pharma

COVID-19 vaccine news continues to roll in and continues to be positive, with AstraZeneca now releasing Phase 3 data that …
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

December 4, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Dupixent, EMA, UK, Vaccine, top ten

As the year winds to a close, excitement is rising around the efficacy and availability of COVID-19 vaccines around the …
shutterstock_159488225

New research links metformin to decreased mortality risk in female patients hospitalised with COVID-19

December 4, 2020 Medical Communications, Research and Development COVID-19, Vaccine, metformin

Researchers from the University of Minnesota Medical School (UMMS) and UnitedHealth Group have uncovered potential benefit of metformin, a generic …
shutterstock_103378880

IBM uncovers “precision phishing campaign” targeting global COVID-19 vaccine cold chain supply

December 4, 2020 Manufacturing and Production, Medical Communications, Research and Development COVID-19, Vaccine, ibm

US tech firm IBM has reported that it has identified attempts by unknown parties to hack and disrupt elements of …
The Gateway to Local Adoption Series

Latest content